Clinical trial
Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)
NCT05923827 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)
- Lead sponsor
- Insulet Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 11, 2023
- Completion date
- February 12, 2026
- Enrollment
- 189 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.